Imunon (IMNN) Long-Term Deferred Tax (2012 - 2023)
Imunon's (IMNN) quarterly Long-Term Deferred Tax came in at $1.3 million in Q4 2023, down 18.29% YoY from $1.6 million in Q4 2022, and down 18.29% on a QoQ basis from $1.6 million in Q4 2022.
Imunon (IMNN) Long-Term Deferred Tax (2012 - 2023) Analysis & Trends
Imunon (IMNN) has 7 years of Long-Term Deferred Tax data on file, last reported at $1.3 million in Q4 2023.
- Quarterly Long-Term Deferred Tax fell 18.29% year-over-year to $1.3 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.3 million (down 18.29% YoY) and the FY2023 annual result came in at $1.3 million, down 18.29% from the prior year.
- Long-Term Deferred Tax slipped to $1.3 million in Q4 2023, from $1.6 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $1.8 million in Q4 2020 to a low of $1.3 million in Q4 2023.
- A 5-year average of $1.6 million and a median of $1.6 million in 2022 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2021 — Long-Term Deferred Tax decreased 25.05% — and 2022, when it increased 13.27%.
- Tracing IMNN's Long-Term Deferred Tax over 5 years: stood at $1.8 million in 2019, then grew by 1.46% to $1.8 million in 2020, then declined by 25.05% to $1.4 million in 2021, then grew by 13.27% to $1.6 million in 2022, then retreated by 18.29% to $1.3 million in 2023.
- The last three Long-Term Deferred Tax figures came in at $1.3 million (Q4 2023), $1.6 million (Q4 2022), and $1.4 million (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Imunon | 8.42 Mn | 8.42 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.28 Mn |
| Dec 31, 2022 | 1.57 Mn |
| Dec 31, 2021 | 1.38 Mn |
| Dec 31, 2020 | 1.85 Mn |
| Dec 31, 2019 | 1.82 Mn |
| Dec 31, 2013 | 56.73 Mn |
| Dec 31, 2012 | 52.09 Mn |